What You’ll Do: Laboratory Oversight & Administrative Provide effective and efficient scientific direction and oversight for the Bilbao laboratory safety and specialty testing (hematology, chemistry, immunoassays, flow cytometry, molecular…) Ensure the development, implementation, and compliance of standardized processes
What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic technology to realize health equity for billions of
The Italian Market Development Manager is responsible for leading the commercial development and market expansion of Cells‑IA (a Spanish digital diagnostics software company specializing in AI‑powered digital pathology solutions and a subsidiary of the pharmaceutical company
Provide effective and efficient scientific direction and oversight for the Bilbao laboratory safety and specialty testing (hematology, chemistry, immunoassays, flow cytometry, molecular…) Ensure the development, implementation, and compliance of standardized processes for CTI central lab Ensure that
In this role you drive growth for Illumina’s oncology portfolio across Italy, serving as a trusted technical advisor to clinicians and researchers. You will partner with cross‑functional teams to accelerate adoption of genomics-based cancer solutions, shaping
JOB DESCRIPTION: Position Overview Exact Sciences provides diagnostic gene assay testing to cancer patients with our Oncotype DX® assay family of products and is leading the way towards individualized medicine. As Genomic Testing in Early Stage
Exact Sciences Italia seeks a Field-based Key Account Manager for Lombardia Ovest, Milan region. You will own the territory with full accountability, building local account strategies, engaging key oncologists and pathologists, and driving adoption of OncoType DX
In this role you drive growth for Illumina’s oncology portfolio across Italy, serving as a trusted technical advisor to clinicians and researchers. You will partner with cross‑functional teams to accelerate adoption of genomics-based cancer solutions, shaping